文献速递生殖医学

高龄与年轻女性IUI临床妊娠结局影响因素分析

[Analysis of factors associated with clinical pregnancy outcomes of IUI in advanced-age and young women].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2026-01-01

回顾性队列分析北京大学第三医院2017至2022年16 884个IUI周期,按年龄分高龄组(≥35岁)与年轻组(<35岁)。年轻组促排卵周期与较高抗苗勒管激素水平为临床妊娠的良性独立预测因素;高龄组仅年龄接近35岁、不孕年限短及处理后前向运动精子总数高为良性独立预测因素,促排卵不能改善其妊娠结局。

要点

  • 年轻组(<35岁)促排卵周期是IUI临床妊娠的良性独立预测因素。
  • 高龄组(≥35岁)促排卵不能作为改善临床妊娠率的措施。
  • 高龄组年龄越接近35岁、不孕年限越短、TPMSC越高,妊娠结局越好。

核心结论

  • 对于年龄<35岁的年轻女性,促排卵治疗是IUI临床妊娠率的良性独立预测因素,有助于提高临床妊娠率。
  • 对于≥35岁的高龄女性,促排卵治疗不能作为改善临床妊娠率的措施,应采用更积极的辅助生殖治疗方式。

研究设计与样本

  • 回顾性队列研究,分析2017年1月至2022年12月北京大学第三医院完成的16 884个IUI周期。
  • 按年龄分为高龄组(≥35岁)和年轻组(<35岁),采用多因素logistic回归分析校正混杂因素。

主要发现

  • 年轻组中,抗苗勒管激素水平(OR=1.050,95%CI为1.028~1.072,P<0.001)和周期类型(自然周期与促排卵周期;OR=0.682,95%CI为0.577~0.806,P<0.001)为临床妊娠的独立预测因素。
  • 高龄组中,年龄(OR=0.932,95%CI为0.879~0.988,P=0.018)、不孕年限(OR=0.938,95%CI为0.893~0.985,P=0.011)、处理后前向运动精子总数(TPMSC;OR=1.018,95%CI为1.002~1.034,P=0.028)为临床妊娠的独立预测因素。

临床怎么用

  • 对<35岁女性行IUI时可考虑促排卵治疗以提高临床妊娠率。
  • 对≥35岁女性,若年龄偏大、不孕年限长或TPMSC低,应更积极采用辅助生殖治疗而非依赖促排卵IUI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the association between various factors and clinical pregnancy outcomes of intrauterine insemination (IUI) in both young and advanced-age women. Methods: This retrospective cohort analysis examined a total of 16 884 IUI cycles performed in Peking University Third Hospital between January 2017 and December 2022. The women were categorized into two groups based on age: the advanced-age group (≥35 years) and the young group (<35 years). Multivariate logistic regression models adjusted for confounders were conducted. Results: In the young group, anti-Müllerian hormone level (OR=1.050, 95%CI: 1.028-1.072, P<0.001), and cycle type (natural cycle vs ovarian stimulation cycle; OR=0.682, 95%CI: 0.578-0.806, P<0.001) were independent predictors of clinical pregnancy. In the advanced-age group, age (OR=0.932, 95%CI: 0.879-0.988, P=0.018), duration of infertility (OR=0.938, 95%CI: 0.893-0.985, P=0.011) and total progressive motile sperm count (TPMSC; OR=1.018, 95%CI: 1.002-1.034, P=0.028) were identified as independent predictors of clinical pregnancy. Conclusions: For women under 35 years old, ovarian stimulation is a favorable independent predictor of clinical pregnancy rate in IUI cycles, and its use could significantly improve clinical pregnancy outcomes. In contrast, for advanced-age women (≥35 years), only younger age, shorter duration of infertility and higher TPMSC are the primary positive independent predictors, and ovarian stimulation cannot be established as a viable strategy to improve pregnancy outcomes, thus a more proactive assisted reproductive treatment should be adopted. 目的: 分析不同年龄段女性宫腔内人工授精(IUI)临床妊娠结局的影响因素。 方法: 回顾性队列研究分析2017年1月至2022年12月期间在北京大学第三医院完成的16 884个IUI周期的临床资料。根据年龄将患者分为高龄组(≥35岁)和年轻组(<35岁),对患者IUI周期的临床资料进行多因素logistic回归分析。 结果: 年轻组IUI患者中,抗苗勒管激素水平(OR=1.050,95%CI为1.028~1.072,P<0.001)、周期类型(自然周期与促排卵周期;OR=0.682,95%CI为0.577~0.806,P<0.001)为临床妊娠的独立预测因素。高龄组IUI患者中,年龄(OR=0.932,95%CI为0.879~0.988,P=0.018)、不孕年限(OR=0.938,95%CI为0.893~0.985,P=0.011)、处理后前向运动精子总数(TPMSC;OR=1.018,95%CI为1.002~1.034,P=0.028)为临床妊娠的独立预测因素。 结论: 对于年龄<35岁的年轻女性,促排卵治疗是IUI临床妊娠率的良性独立预测因素,通过采用促排卵治疗有助于提高临床妊娠率。对于≥35岁的高龄女性,年龄越接近35岁、不孕年限短和处理后TPMSC高是良性独立预测因素,促排卵治疗并不能作为改善其临床妊娠率的措施,应采用更积极的辅助生殖治疗方式。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tu BB, Zhang J, Zhao J, et al. [Analysis of factors associated with clinical pregnancy outcomes of IUI in advanced-age and young women]. Zhonghua Fu Chan Ke Za Zhi. 2026. PMID: 41866198. doi:10.3760/cma.j.cn112141-20251013-00488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。